FDA Draft Guidance: Considerations for Complying with 21 CFR 211.110
FDA's January 2025 draft on 21 CFR 211.110 outlines CGMP measures for batch uniformity, drug integrity, and advanced manufacturing innovation
FDA Issues Warning Letter to LS Promotions Inc. for cGMP Violations
FDA issues warning to LS Promotions Inc. for significant cGMP violations. Learn about the key deficiencies, recommended CAPA plan, and steps for compliance.
Cleaning Validation In the Pharmaceutical Industry
Explore the essentials of cleaning validation in the pharmaceutical industry, including all necessary steps, challenges, and regulatory standards.
GMP vs cGMP: Understanding the Differences
Discover the key differences between GMP vs cGMP to ensure product quality and compliance with regulations for your manufacturing processes.